| First Author | Schwarz EM | Year | 1997 |
| Journal | Genes Dev | Volume | 11 |
| Issue | 2 | Pages | 187-97 |
| PubMed ID | 9009202 | Mgi Jnum | J:38092 |
| Mgi Id | MGI:85481 | Doi | 10.1101/gad.11.2.187 |
| Citation | Schwarz EM, et al. (1997) Immunological defects in mice with a targeted disruption in Bcl-3. Genes Dev 11(2):187-97 |
| abstractText | The proto-oncogene bcl-3 is a member of the IkappaB family. The Bcl-3 protein is known to interact specifically with the p50 and p52 subunits of NFkappaB. However, the function of this interaction is not well understood. To determine the in vivo role of Bcl-3, mice were generated that lack the bcl-3 gene, Bcl 3(-/-). Here we report that Bcl 3(-/-) mice appear developmentally normal, but exhibit severe defects in humoral immune responses and protection from in vivo pathogenic challenges. Relative to wild-type mice, Bcl 3(-/-) mice are unable to clear L. monocytogenes and are more susceptible to infection with S. pneumoniae. This phenotype is similar to that observed in the p50(-/-) mice and the cross between the Bcl-3(-/-) and p50(-/-) mice generates animals with an enhanced phenotype. In accordance with the observed defects in their immune response, the Bcl 3(-/-) mice have normal immunoglobulin levels before and after immunization, but fail to produce antigen-specific antibodies. Additionally, spleens from Bcl-3(-/-) mice are abnormal and void of germinal centers. In contrast, the p50(-/-) mice have normal germinal centers. We propose that in in vivo, Bcl-3 can function independently of p50. |
